Neutralization of staphylococcal exotoxins in vitro by human-origin intravenous immunoglobulin

Journal of Infection and Chemotherapy

Volumn 13, Issue 6, 2007, Pages 368-372

  Yanagisawa, Chie ^a   Hanaki, Hideaki ^a   Natae, Taiji ^a   Sunakawa, Keisuke ^a  

^a KITASATO UNIVERSITY   (Japan)

Author keywords

Exotoxin; Intravenous immunoglobulin (IVIG); Methicillin resistant Staphylococcus aureus (MRSA)

Indexed keywords

ENTEROTOXIN; HEMOLYSIN; IMMUNOGLOBULIN; STAPHYLOCOCCUS TOXIN; TOXIC SHOCK SYNDROME TOXIN 1;

ARTICLE; BACTERIA NEUTRALIZATION; BACTERIAL STRAIN; BACTERIUM CULTURE; CELL AGGREGATION; DILUTION; ERYTHROCYTE COUNT; HEMOLYSIS; HUMAN; HUMAN CELL; IMMUNOLOGICAL PROCEDURES; IN VITRO STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; SHEEP; STAPHYLOCOCCUS AUREUS; SUPERNATANT;

BACTERIAL TOXINS; ENTEROTOXINS; EXOTOXINS; HEMOLYSIN PROTEINS; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; LATEX FIXATION TESTS; METHICILLIN RESISTANCE; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; SUPERANTIGENS;

EID: 37349132468     PISSN: 1341321X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10156-007-0551-6     Document Type: Article

References (22)

1. Knopf HJ. Nosocomial infections caused by multiresistant pathogens. Clinical management exemplified by multiresistant Staphylococcus aureus. Urologe A 1997;36:248-54.
2. Chambers HF. The changing epidemiology of Staphylococcus aureus. Emerg Infect Dis 2001;7:178-82.
3. Marchese A, Schito GC, Debbia EA. Emergence of drug-resistant gram-positive pathogenic bacteria (in Italian). J Chemother 2000;12:12-4.
4. Dinges MM, Orwin PM, Schlievert PM. Exotoxins of Staphylococcus aureus. Clin Microbiol Rev 2000;13:16-34.
5. Katayama T, Mino T, Inaoka C, Fujiwara F, Miyamichi T, Nakayama M. Coagulase typing, production of toxin, drug sensibility, Staphylococcus aureus (in Japanese). J Osaka Med-Center & Res Inst Mater-Child-Health 2005;21:24-7.
6. Schmitz FJ, MacKenzie CR, Geisel R, Wagner S, Idel H, Verhoef J, et al. Enterotoxin and toxic shock syndrome toxin-1 production of methicillin resistant and methicillin sensitive Staphylococcus aureus strains. Eur J Epidemiol 1997;13:699-708.
7. Wiseman GM. The hemolysins of Staphylococcus aureus. Bacteriol Rev 1975;39:317-44.
8. Piao C, Karasawa T, Totsuka K, Uchiyama T, Kikuchi K. Prospective surveillance of community-onset and healthcare-associated methicillin-resistant Staphylococcus aureus isolated from a university-affiliated hospital in Japan. Microbiol Immunol 2005;49:959-70.
9. Bernel A, Proft T, Fraser JD, Posnett DN. Superantigens in human disease. J Clin Immunol 1999;19:149-57.
10. Labrecque NJ, Thibodeau J, Sékaly RP. Interactions between staphylococcal superantigens and MHC class II molecules. Semin Immunol 1993;5:23-32.
11. Uchiyama T, Yan XJ, Imanishi K, Yagi J. Bacterial superantigens-mechanism of T cell activation by the superantigens and their role in the pathogenesis of infectious diseases. Microbiol Immunol 1994;38:245-56.
12. Hurley JM, Shimonkevitz R, Hanagan A, Enney K, Boen E, Malmstrom S, et al. Identification of class II major histocompatibility complex and T cell receptor binding sites in the superantigen toxic shock syndrome toxin 1. J Exp Med 1995;181:2229-35.
13. Nakae T, Hirayama F, Hashimoto M. Neutralizing activity of human immunoglobulin preparation against toxic shock syndrome toxin-1 (in Japanese). Kansenshogaku Zasshi 2002;76:195-202.
14. Aarestrup F, Larsen H, Eriksen N, Elsberg C, Jensen N. Frequency of α- and β-hemolysin in Staphylococcus aureus of bovine and human origin. APMIS 1999;107:425-30.
15. Mehrotra M, Wang G, Johnson WM. Multiplex PCR for detection of genes for Staphylococcus aureus enterotoxins, exfoliative toxins, toxic shock syndrome toxin 1, and methicillin resistance. J Clin Microbiol 2000;38:1032-5.
16. Kitamura K, Mikami Y. Analysis of the physicochemical and biochemical property of various intravenous immunoglobulin preparations. Biotherapy 2002;16:467-76.
17. Rayner C, Munckhof WJ. Antibiotics currently used in the treatment of infections caused by Staphylococcus aureus. Intern Med J 2005;35:3-16.
18. Schlievert PM. Role of superantigens in human disease. J Infect Dis 1993;167:997-1002.
19. Panlilio AL, Culver DH, Gaynes RP, Banerjee S, Henderson TS, Tolson JS, et al. Methicillin-resistant Staphylococcus aureus in U.S. hospitals, 1975-1991. Infect Control Hosp Epidemiol 1992;13:582-6.
20. Todd JK. Staphylococcal infections. Pediatr Rev 2005;26:444-50.
21. Schaad UB. Syndromes caused by staphylococcal toxins (in German). Schweiz Rundsch Med Prax 1985 22;74:1175-9.
22. Syuji T, Yogesh KA, Sharyn MW. Intravenous immunoglobulin contains specific antibodies inhibitory to activation of T cells by staphylococcal toxin superantigens. J Clin Invest 1993;91:602-7.